Practice Management News

The AMA announced a new policy that supports requirements for drug and device sponsors to develop diversity action plans so that women and sexual and gender minorities are adequately represented in their clinical trials.

The AMA House of Delegates adopted two new policies aiming to reform prior authorization and the burden it causes patients and physicians.

On May 8, the health care organization Ascension experienced a cyberattack that disrupted access to its electronic health care records, patient portals, phones and systems used to order tests, medications and procedures.

Financial independence is the holy grail, which affords one to work for the sake of working with the peace of mind of knowing they are no longer dependent on a paycheck to maintain their lifestyle.

Due to demographic changes and a rise in risk factors, the prevalence and economic burden of heart disease and stroke in the United States are expected to increase dramatically by 2050, according to the American Heart Association.

One of the most important questions physicians will need to answer is whether they will hire a financial advisor to help them manage their wealth or do it themselves.

The FDA has cleared an investigational new drug application for an alpha-kinase 1 inhibitor for clinical evaluation in those with retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis and headache, or ROSAH, syndrome.

The Foundation for the NIH has announced the launch of a public-private partnership to advance knowledge of and accelerate drug development for individuals affected by amyotrophic lateral sclerosis.

Any doctor seeing patients has had to field questions unrelated to their specialty.

For those with epilepsy who may become pregnant and their potential offspring, medications must optimize seizure control as well as outcomes for the fetus, according to new guidelines presented in Neurology.